Moderna (MRNA) Shares Outstanding (2017 - 2026)
Moderna (MRNA) posted quarterly Shares Outstanding (Entity) of $399.0 million for Q2 2026, up 2.57% year-over-year from $389.0 million in Q2 2025, and up 0.5% on a QoQ basis from $397.0 million in Q1 2026.
Moderna (MRNA) Shares Outstanding (2017 - 2026) Analysis & Trends
Moderna has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $399.0 million in Q2 2026.
- Shares Outstanding (Entity) for Q2 2026 came in at $399.0 million, up 2.57% year-over-year; the trailing twelve-month figure through Jun 2026 was $399.0 million (up 2.57% YoY), and the FY2025 annual result was $394.0 million, up 2.07% from the prior year.
- Shares Outstanding (Entity) improved to $399.0 million in Q2 2026, from $397.0 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $400.0 million in Q1 2022 and troughed at $381.0 million in Q2 2023.
- A 5-year average of $388.2 million and a median of $386.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2022, when Shares Outstanding (Entity) decreased 4.47%; it then rose 2.58% in 2026.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $385.0 million in 2022, then dropped by 0.78% to $382.0 million in 2023, then advanced by 1.05% to $386.0 million in 2024, then rose by 2.07% to $394.0 million in 2025, then climbed by 1.27% to $399.0 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $399.0 million in Q2 2026, $397.0 million in Q1 2026, and $394.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 398.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 398.00 Mn |
| Mar 31, 2026 | 395.00 Mn |
| Dec 31, 2025 | 389.00 Mn |
| Sep 30, 2025 | 390.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | 386.00 Mn |
| Dec 31, 2024 | 384.00 Mn |
| Sep 30, 2024 | 385.00 Mn |
| Jun 30, 2024 | 384.00 Mn |
| Mar 31, 2024 | 382.00 Mn |
| Dec 31, 2023 | 382.00 Mn |
| Sep 30, 2023 | 381.00 Mn |
| Jun 30, 2023 | 381.00 Mn |
| Mar 31, 2023 | 386.00 Mn |
| Dec 31, 2022 | 394.00 Mn |
| Sep 30, 2022 | 390.00 Mn |
| Jun 30, 2022 | 396.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 403.00 Mn |
| Sep 30, 2021 | 404.00 Mn |